Light beams to the brain: a new hope for lewy body disease?
NCT ID NCT07602296
First seen May 27, 2026 · Last updated Jun 15, 2026 · Updated 7 times
Summary
This study tests a new, non-invasive light therapy (photobiomodulation) for people with Lewy body disease, a common type of dementia. The treatment uses red and infrared light to stimulate brain cells, aiming to improve thinking, movement, and quality of life. Forty adults aged 50 and older with mild to moderate symptoms will receive either the light therapy or a placebo, and their progress will be tracked for six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEWY BODIES DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67000, France
Conditions
Explore the condition pages connected to this study.